Literature DB >> 20736375

Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition.

Sung-Young Shin1, Oliver Rath, Armin Zebisch, Sang-Mok Choo, Walter Kolch, Kwang-Hyun Cho.   

Abstract

Epithelial-mesenchymal transition (EMT) is a key event in the generation of invasive tumor cells. A hallmark of EMT is the repression of E-cadherin expression, which is regulated by various signal transduction pathways including extracellular signal-regulated kinase (ERK) and Wnt. These pathways are highly interconnected via multiple coupled feedback loops (CFL). As the function of such coupled feedback regulations is difficult to analyze experimentally, we used a systems biology approach where computational models were designed to predict biological effects that result from the complex interplay of CFLs. Using epidermal growth factor (EGF) and Wnt as input and E-cadherin transcriptional regulation as output, we established an ordinary differential equation model of the ERK and Wnt signaling network containing six feedback links and used extensive computer simulations to analyze the effects of these feedback links in isolation and different combinations. The results show that the feedbacks can generate a rich dynamic behavior leading to various dose-response patterns and have a decisive role in determining network responses to EGF and Wnt. In particular, we made two important findings: first, that coupled positive feedback loops composed of phosphorylation of Raf kinase inhibitor RKIP by ERK and transcriptional repression of RKIP by Snail have an essential role in causing a switch-like behavior of E-cadherin expression; and second, that RKIP expression inhibits EMT progression by preventing E-cadherin suppression. Taken together, our findings provide us with a system-level understanding of how RKIP can regulate EMT progression and may explain why RKIP is downregulated in so many metastatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736375      PMCID: PMC3012452          DOI: 10.1158/0008-5472.CAN-10-1377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Epithelial-mesenchymal transition.

Authors:  Derek C Radisky
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

2.  Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.

Authors:  Maria Almeida; Li Han; Teresita Bellido; Stavros C Manolagas; Stavroula Kousteni
Journal:  J Biol Chem       Date:  2005-10-25       Impact factor: 5.157

3.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.

Authors:  K Yeung; T Seitz; S Li; P Janosch; B McFerran; C Kaiser; F Fee; K D Katsanakis; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

4.  Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.

Authors:  Suzanne Hagan; Fahd Al-Mulla; Elizabeth Mallon; Karin Oien; Rhona Ferrier; Barry Gusterson; Jorge J Curto García; Walter Kolch
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

Review 5.  The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.

Authors:  Evan T Keller; Zheng Fu; Meghan Brennan
Journal:  J Cell Biochem       Date:  2005-02-01       Impact factor: 4.429

6.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Authors:  Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung-Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C Bargou; Jun Qin; Chien-Chen Lai; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

7.  Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.

Authors:  Binhua P Zhou; Jiong Deng; Weiya Xia; Jihong Xu; Yan M Li; Mehmet Gunduz; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2004-09-26       Impact factor: 28.824

8.  SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways.

Authors:  S B Waters; K H Holt; J E Pessin
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 9.  Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.

Authors:  Evan T Keller; Zheng Fu; Kam Yeung; Meghan Brennan
Journal:  Cancer Lett       Date:  2004-04-30       Impact factor: 8.679

10.  The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.

Authors:  Ethan Lee; Adrian Salic; Roland Krüger; Reinhart Heinrich; Marc W Kirschner
Journal:  PLoS Biol       Date:  2003-10-13       Impact factor: 8.029

View more
  62 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma and their correlations.

Authors:  Fu-Min Ping; Gui-Jing Liu; Zhi-Jun Liu; Hai-Bin Li; Jian-Wen Zhai; Shu-Xia Li; Yue-Mei Liu; Bao-Wei Li; Hong Wei
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Status of targeted therapies in the adjuvant treatment of colon cancer.

Authors:  Valerie M Nelson; Al B Benson
Journal:  J Gastrointest Oncol       Date:  2013-09

4.  Epithelial mesenchymal transition and lung cancer.

Authors:  Dakai Xiao; Jianxing He
Journal:  J Thorac Dis       Date:  2010-09       Impact factor: 2.895

5.  Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

Authors:  Steven R Alberts; Daniel J Sargent; Suresh Nair; Michelle R Mahoney; Margaret Mooney; Stephen N Thibodeau; Thomas C Smyrk; Frank A Sinicrope; Emily Chan; Sharlene Gill; Morton S Kahlenberg; Anthony F Shields; James T Quesenberry; Thomas A Webb; Gist H Farr; Barbara A Pockaj; Axel Grothey; Richard M Goldberg
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

6.  Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation.

Authors:  Steven Nathaniel Steinway; Jorge G T Zañudo; Wei Ding; Carl Bart Rountree; David J Feith; Thomas P Loughran; Reka Albert
Journal:  Cancer Res       Date:  2014-09-04       Impact factor: 12.701

7.  Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma.

Authors:  Fengchun Hu; Xiaohua Chen; Xiqiang Liu; Cheng Wang; Lanhai Lv; Nan Xie; Tianyi Wang; Hongzhang Huang
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

8.  Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Authors:  Min Tao; Yingfeng Shi; Lunxian Tang; Yi Wang; Lu Fang; Wei Jiang; Tao Lin; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

9.  Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Authors:  Xiaojie Xu; Zhongyi Fan; Lei Kang; Juqiang Han; Chengying Jiang; Xiaofei Zheng; Ziman Zhu; Huabo Jiao; Jing Lin; Kai Jiang; Lihua Ding; Hao Zhang; Long Cheng; Hanjiang Fu; Yi Song; Ying Jiang; Jiahong Liu; Rongfu Wang; Nan Du; Qinong Ye
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 10.  The dynamic control of signal transduction networks in cancer cells.

Authors:  Walter Kolch; Melinda Halasz; Marina Granovskaya; Boris N Kholodenko
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.